Merck to buy Prometheus Biosciences for about $11 billion

·

·

Merck to buy Prometheus Biosciences for about $11 billion

Davis said the Prometheus drug, PRA023, being developed to treat ulcerative colitis, Crohn’s disease, and other autoimmune conditions, could be a multibillion-dollar seller for Merck. He said the recent release of encouraging Phase II clinical trial …
See Original Article

Accounting Practice Management Market 2023 Trends with Analysis on Key Players Senta …

Growth in the Accounting Practice Management business is also expected to be supported by trends such as the increasing importance of agreements and
See Original Article

Obituary for Larry Paul Crain, Searcy, AR – The Northwest Arkansas Democrat-Gazette

After graduating from Searcy High School in 1959, Larry began his studies in accounting at the University of Arkansas.
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.